Bank Of New York Mellon Corp Jounce Therapeutics, Inc. Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.64 - $1.99 $85,555 - $266,023	133,680 New	133,680 $148,000
Q3 2022 Nov 14, 2022	BUY	$2.73 - $4.92 $49,931 - $89,986	18,290 Added 14.47%	144,700 $339,000
Q2 2022 Aug 15, 2022	SELL	$2.8 - $7.67 $2,357 - $6,458	-842 Reduced 0.66%	126,410 $383,000
Q1 2022 May 11, 2022	BUY	$6.01 - $8.54 $1,484 - $2,109	247 Added 0.19%	127,252 $865,000
Q4 2021 Feb 11, 2022	SELL	$7.11 - $9.64 $7,636 - $10,353	-1,074 Reduced 0.84%	127,005 $1.06 Million
Q3 2021 Nov 12, 2021	BUY	$5.04 - $8.73 $130,087 - $225,330	25,811 Added 25.24%	128,079 $952,000
Q2 2021 Aug 11, 2021	BUY	$6.58 - $10.66 $204,618 - $331,494	31,097 Added 43.69%	102,268 $695,000
Q1 2021 May 13, 2021	SELL	$6.73 - $13.87 $5,848 - $12,053	-869 Reduced 1.21%	71,171 $730,000
Q4 2020 Feb 09, 2021	SELL	$6.37 - $10.33 $727,753 - $1.18 Million	-114,247 Reduced 61.33%	72,040 $504,000
Q3 2020 Nov 12, 2020	SELL	$4.58 - $10.95 $65,782 - $157,274	-14,363 Reduced 7.16%	186,287 $1.52 Million
Q2 2020 Aug 12, 2020	SELL	$4.17 - $7.58 $34,848 - $63,346	-8,357 Reduced 4.0%	200,650 $1.38 Million
Q1 2020 May 06, 2020	SELL	$2.91 - $8.7 $32,370 - $96,778	-11,124 Reduced 5.05%	209,007 $992,000
Q4 2019 Feb 14, 2020	BUY	$2.81 - $9.21 $379,251 - $1.24 Million	134,965 Added 158.47%	220,131 $1.92 Million
Q3 2019 Nov 07, 2019	BUY	$3.33 - $4.93 $482 - $714	145 Added 0.17%	85,166 $283,000
Q2 2019 Aug 12, 2019	BUY	$4.3 - $6.73 $74,037 - $115,877	17,218 Added 25.39%	85,021 $421,000
Q1 2019 May 14, 2019	SELL	$3.43 - $6.87 $4,338 - $8,690	-1,265 Reduced 1.83%	67,803 $420,000
Q4 2018 Feb 11, 2019	BUY	$2.69 - $6.71 $57,767 - $144,097	21,475 Added 45.12%	69,068 $233,000
Q3 2018 Nov 09, 2018	BUY	$6.5 - $8.37 $162 - $209	25 Added 0.05%	47,593 $0
Q2 2018 Aug 06, 2018	SELL	$7.27 - $21.88 $7,793 - $23,455	-1,072 Reduced 2.2%	47,568 $365,000
Q1 2018 May 15, 2018	BUY	$13.4 - $28.4 $36,863 - $78,128	2,751 Added 5.99%	48,640 $1.09 Million
Q4 2017 Feb 09, 2018	BUY	$12.52 - $17.82 $574,530 - $817,741	45,889	45,889 $585,000

Others Institutions Holding JNCE

# of Institutions

Shares Held

720K

Call Options Held

Put Options Held

View Full List

About Jounce Therapeutics, Inc.

Ticker JNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,694,200
Description
Jounce Therapeutics, Inc., a clinical-stage immunotherapy company, develops therapies for the treatment of cancer. The company develops vopratelimab, a clinical-stage monoclonal antibody, which is in Phase II clinical trial that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of T cells found in various solid ...

More about JNCE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account